Copyright
©The Author(s) 2019.
World J Clin Cases. May 6, 2019; 7(9): 1080-1086
Published online May 6, 2019. doi: 10.12998/wjcc.v7.i9.1080
Published online May 6, 2019. doi: 10.12998/wjcc.v7.i9.1080
Author | Therapy line | Initial dose | Liver injury | Occurrence time | Outcome |
Ripault et al[18], 2013 | Not mentioned | 500 mg Qd | Acute hepatitis | Day 60 | Transaminases returned to normal |
Sato et al[19], 2014 | First-line | 400 mg Qd | Fulminant hepatitis | Day 29 | Died of liver failure |
Van Geel et al[20], 2016 | Second-line | 250 mg Bid | Fulminant liver failure | Day 24 | Died of liver failure |
Yasuda et al[21], 2017 | Second-line | 250 mg Bid | Hepatitis | Day 16 | Died of respiratory failure |
Present case | First-line | 250 mg Bid | Fulminant liver failure | Day 46 | Died of liver failure |
- Citation: Zhang Y, Xu YY, Chen Y, Li JN, Wang Y. Crizotinib-induced acute fatal liver failure in an Asian ALK-positive lung adenocarcinoma patient with liver metastasis: A case report. World J Clin Cases 2019; 7(9): 1080-1086
- URL: https://www.wjgnet.com/2307-8960/full/v7/i9/1080.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i9.1080